Hotchkis & Wiley Capital Management LLC purchased a new stake in Envista Holdings Co. (NYSE:NVST - Free Report) during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The firm purchased 757,330 shares of the company's stock, valued at approximately $14,965,000. Hotchkis & Wiley Capital Management LLC owned 0.44% of Envista as of its most recent filing with the SEC.
Other institutional investors have also recently added to or reduced their stakes in the company. Mirae Asset Global Investments Co. Ltd. acquired a new stake in Envista in the 3rd quarter valued at $31,000. GAMMA Investing LLC lifted its holdings in Envista by 69.8% in the 3rd quarter. GAMMA Investing LLC now owns 1,766 shares of the company's stock valued at $35,000 after purchasing an additional 726 shares in the last quarter. Huntington National Bank lifted its holdings in Envista by 97.8% in the 3rd quarter. Huntington National Bank now owns 1,919 shares of the company's stock valued at $38,000 after purchasing an additional 949 shares in the last quarter. Blue Trust Inc. lifted its holdings in Envista by 69.7% in the 3rd quarter. Blue Trust Inc. now owns 1,957 shares of the company's stock valued at $39,000 after purchasing an additional 804 shares in the last quarter. Finally, Allspring Global Investments Holdings LLC lifted its holdings in Envista by 50.8% in the 3rd quarter. Allspring Global Investments Holdings LLC now owns 2,161 shares of the company's stock valued at $43,000 after purchasing an additional 728 shares in the last quarter.
Wall Street Analyst Weigh In
A number of brokerages have weighed in on NVST. Stifel Nicolaus raised their price objective on Envista from $18.00 to $21.00 and gave the company a "buy" rating in a report on Wednesday, October 23rd. Leerink Partnrs upgraded Envista from a "strong sell" rating to a "hold" rating in a report on Thursday, October 31st. Leerink Partners upgraded Envista from an "underperform" rating to a "market perform" rating and lifted their price target for the stock from $16.00 to $23.00 in a report on Thursday, October 31st. Piper Sandler raised their price objective on Envista from $16.00 to $17.00 and gave the stock a "neutral" rating in a research report on Thursday, October 31st. Finally, Robert W. Baird raised their price objective on Envista from $17.00 to $22.00 and gave the stock a "neutral" rating in a research report on Thursday, October 31st. Two analysts have rated the stock with a sell rating, eleven have given a hold rating and three have given a buy rating to the company's stock. Based on data from MarketBeat, the company currently has an average rating of "Hold" and an average price target of $20.65.
Check Out Our Latest Report on NVST
Envista Stock Down 6.5 %
Shares of Envista stock traded down $1.43 on Wednesday, reaching $20.57. 2,954,194 shares of the company were exchanged, compared to its average volume of 2,382,204. The stock's 50 day moving average price is $19.96 and its 200-day moving average price is $18.34. The company has a market cap of $3.54 billion, a P/E ratio of -2.65, a price-to-earnings-growth ratio of 3.10 and a beta of 1.31. Envista Holdings Co. has a 1-year low of $15.15 and a 1-year high of $25.64. The company has a debt-to-equity ratio of 0.42, a current ratio of 2.08 and a quick ratio of 1.77.
Envista (NYSE:NVST - Get Free Report) last posted its earnings results on Wednesday, October 30th. The company reported $0.12 earnings per share for the quarter, topping the consensus estimate of $0.09 by $0.03. The firm had revenue of $601.00 million during the quarter, compared to analysts' expectations of $590.34 million. Envista had a positive return on equity of 3.76% and a negative net margin of 53.42%. The firm's revenue was down 4.8% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.43 earnings per share. As a group, equities analysts forecast that Envista Holdings Co. will post 0.72 EPS for the current year.
Envista Profile
(
Free Report)
Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.
Further Reading
Before you consider Envista, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Envista wasn't on the list.
While Envista currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
